Truist Financial Cuts Ardent Health (NYSE:ARDT) Price Target to $12.00

Ardent Health (NYSE:ARDT) had its price objective decreased by Truist Financial from $13.00 to $12.00 in a report issued on Tuesday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

Other equities research analysts also recently issued research reports about the company. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Royal Bank Of Canada cut their target price on Ardent Health from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, July 9th. Wall Street Zen lowered Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Finally, UBS Group increased their target price on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a report on Thursday, May 7th. Seven investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Ardent Health has a consensus rating of “Hold” and an average target price of $14.04.

Ardent Health Stock Performance

NYSE ARDT opened at $10.18 on Tuesday. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $1.46 billion, a P/E ratio of 10.71, a P/E/G ratio of 2.30 and a beta of 0.76. Ardent Health has a 12-month low of $7.71 and a 12-month high of $15.48. The firm has a 50-day moving average price of $9.62 and a two-hundred day moving average price of $9.28.

Ardent Health (NYSE:ARDT) last announced its earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Analysts anticipate that Ardent Health will post 1.06 earnings per share for the current year.

Insider Activity

In other news, CFO Alfred Lumsdaine acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average cost of $8.81 per share, with a total value of $88,100.00. Following the completion of the purchase, the chief financial officer directly owned 329,183 shares of the company’s stock, valued at $2,900,102.23. The trade was a 3.13% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.90% of the company’s stock.

Institutional Investors Weigh In On Ardent Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company boosted its holdings in shares of Ardent Health by 3.7% in the 1st quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock valued at $255,000 after purchasing an additional 1,072 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after buying an additional 1,769 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in shares of Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after buying an additional 2,638 shares in the last quarter. Alliancebernstein L.P. lifted its position in shares of Ardent Health by 24.8% during the 3rd quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock worth $218,000 after buying an additional 3,272 shares during the last quarter. Finally, New York State Common Retirement Fund lifted its position in shares of Ardent Health by 121.4% during the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after buying an additional 3,400 shares during the last quarter.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.